Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitezealandpharma.com
Twitter@ZealandPharma
CategoryBioTech
Phone45-88-77-36-00
Emailinfo@zealandpharm...
Employees
DescriptionBiotechnology company

Offices

Copenhagen, DNK
Smedeland 36
Copenhagen, 2600, DNK

People

Chairman of The Supervisory Board
Board Member
Board memeber

Tags

Zealand Pharma

Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) is a biotechnology company based in Copenhagen, Denmark. Zealand Pharma specializes in the discovery, optimization and development of novel peptide drugs and has a broad and mature pipeline of drug candidates identified through its own drug discovery activities. The company’s focus lies in the field of diabetes/metabolic diseases, and its lead drug invention is lixisenatide (Lyxumia® 1), a once-daily GLP-1 agonist, which is licensed to Sanofi for the treatment of Type 2 diabetes. Lixisenatide is currently under regulatory review in a large number of countries globally, and in November 2012 the European Committee for Human Medicinal Products issued a positive recommendation for approval of the product in Europe.

Recent Milestones

Videos

Screenshots

Zealand Pharma screenshot
Above: Zealand Pharma
Uploaded: 2/12/13

Sources

Edit This Page
Last Edited 9/9/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy